Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China
· Delayed Price · Currency is CNY 26.45
+0.30 (1.15%)
Apr 29, 2026, 3:00 PM CST
SHA:600645 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 99.74 | 103.53 | 100.35 | 106.45 | 112.99 | 155.32 | Upgrade
|
| Depreciation & Amortization | 139.32 | 139.32 | 133.4 | 143.6 | 138.21 | 124.62 | Upgrade
|
| Other Amortization | 25.64 | 25.64 | 36.67 | 29.02 | 26.12 | 23.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | -6.41 | -6.41 | -1.3 | -3.67 | -2.03 | -1.49 | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.69 | 10.69 | 4.68 | 0.31 | 0.8 | 27.64 | Upgrade
|
| Loss (Gain) From Sale of Investments | 13.67 | 13.67 | 44.33 | 47.94 | 8.71 | -85.87 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 27.68 | 20.9 | 17.63 | 38.21 | Upgrade
|
| Other Operating Activities | 3.56 | 18.02 | 3.12 | 2.09 | -2.04 | -5.18 | Upgrade
|
| Change in Accounts Receivable | -20.2 | -20.2 | -31.23 | -12.23 | -31.93 | 30.73 | Upgrade
|
| Change in Inventory | -7.36 | -7.36 | -0.63 | -9.25 | -27.64 | -4.56 | Upgrade
|
| Change in Accounts Payable | -3.37 | -3.37 | -11.18 | -1.07 | 35.06 | 19.42 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -0.03 | 12.21 | -6.68 | -19.46 | Upgrade
|
| Operating Cash Flow | 295.38 | 313.63 | 285.19 | 299.02 | 261.89 | 320.96 | Upgrade
|
| Operating Cash Flow Growth | -4.77% | 9.97% | -4.62% | 14.18% | -18.40% | 31.35% | Upgrade
|
| Capital Expenditures | -46.84 | -49.56 | -67.32 | -88.61 | -99.19 | -127.74 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.33 | 0.31 | 0.78 | 0.19 | 1.42 | 12.63 | Upgrade
|
| Investment in Securities | -145.34 | -710.33 | 1.95 | -2.06 | -0.57 | -18.95 | Upgrade
|
| Other Investing Activities | 14.3 | 11.74 | 0.72 | - | - | - | Upgrade
|
| Investing Cash Flow | -177.56 | -747.85 | -63.86 | -90.49 | -98.34 | -134.05 | Upgrade
|
| Long-Term Debt Repaid | - | - | -41.19 | -35.76 | -41.33 | -29.13 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -41.19 | -35.76 | -41.33 | -29.13 | Upgrade
|
| Repurchase of Common Stock | - | - | -200.03 | - | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -1.61 | Upgrade
|
| Other Financing Activities | -71.95 | -74.1 | -43.69 | 17.03 | 33.58 | -18.97 | Upgrade
|
| Financing Cash Flow | -71.95 | -74.1 | -284.91 | -18.73 | -7.75 | -49.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | -13.04 | -9.25 | 7.3 | 10.22 | 35.3 | -7.44 | Upgrade
|
| Net Cash Flow | 32.83 | -517.56 | -56.28 | 200.02 | 191.1 | 129.75 | Upgrade
|
| Free Cash Flow | 248.55 | 264.07 | 217.87 | 210.4 | 162.7 | 193.22 | Upgrade
|
| Free Cash Flow Growth | -1.54% | 21.21% | 3.55% | 29.32% | -15.79% | 26.59% | Upgrade
|
| Free Cash Flow Margin | 17.48% | 18.15% | 13.74% | 13.23% | 10.46% | 12.58% | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.58 | 0.48 | 0.46 | 0.35 | 0.41 | Upgrade
|
| Cash Interest Paid | - | - | 0.59 | 0.92 | 1.27 | - | Upgrade
|
| Cash Income Tax Paid | 164.51 | 159.44 | 162.15 | 170.94 | 110.96 | 116.78 | Upgrade
|
| Levered Free Cash Flow | 217.1 | 225.03 | 189.08 | 164.65 | 141.27 | 197.98 | Upgrade
|
| Unlevered Free Cash Flow | 217.1 | 225.03 | 192.22 | 167.79 | 143.78 | 199.95 | Upgrade
|
| Change in Working Capital | 9.17 | 9.17 | -63.75 | -47.63 | -38.49 | 44.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.